Publications by authors named "Hidetomo Kitamura"

Claim this Profile
E
Endometrial Disease in Six Cats with Clinical and Histopathological Features Resembling Atypical Endometrial Hyperplasia in Humans.
Satoshi Suzuki, Hidetomo Kitamura, Kohtaro Hayashi, Tomomi Nakashima, Masaru Okamura

J Comp Pathol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel myostatin-specific antibody enhances muscle strength in muscle disease models.
Hiroyasu Muramatsu, Taichi Kuramochi, Hitoshi Katada, Atsunori Ueyama, Yoshinao Ruike, Hidetomo Kitamura

Sci Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead Optimization and Avoidance of Reactive Metabolite Leading to PCO371, a Potent, Selective, and Orally Available Human Parathyroid Hormone Receptor 1 (hPTHR1) Agonist.
Yoshikazu Nishimura, Toru Esaki, Yoshiaki Isshiki, Yoshiyuki Furuta, Akemi Mizutani, Hidetomo Kitamura

J Med Chem· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cynomolgus monkey model of interleukin-31-induced scratching depicts blockade of human interleukin-31 receptor A by a humanized monoclonal antibody.
Sohei Oyama, Hidetomo Kitamura, Taichi Kuramochi, Yoshinobu Higuchi, Hiroaki Matsushita

Exp Dermatol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In Vitro.
Mariko Noguchi-Sasaki, Tetsuhiro Soeda, Atsunori Ueyama, Atsushi Muto, Michinori Hirata, Hidetomo Kitamura

TH Open· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism.
Tatsuya Tamura, Hiroshi Noda, Eri Joyashiki, Maiko Hoshino, Tomoyuki Watanabe, Hidetomo Kitamura

Nat Commun· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models.
Tatsuya Tamura, Yoshinobu Higuchi, Hidetomo Kitamura, Naoaki Murao, Ryoichi Saitoh

Arthritis Res Ther· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models.
Tatsuya Tamura, Yoshinobu Higuchi, Hidetomo Kitamura, Naoaki Murao, Ryoichi Saitoh

Arthritis Res Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and optimization of hyaluronic acid-methotrexate conjugates to maximize benefit in the treatment of osteoarthritis.
Akie Homma, Haruhiko Sato, Tatsuya Tamura, Akira Okamachi, Takashi Emura, Hidetomo Kitamura

Bioorg Med Chem· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice.
Takei Kake, Hidetomo Kitamura, Yuichiro Adachi, Tetsuro Yoshioka, Tomoyuki Watanabe

Am J Physiol Endocrinol Metab· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.
Akihiro Yasoda, Hidetomo Kitamura, Toshihito Fujii, Eri Kondo, Naoaki Murao

Endocrinology· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel hyaluronic acid-methotrexate conjugates for osteoarthritis treatment.
Akie Homma, Haruhiko Sato, Akira Okamachi, Takashi Emura, Takenori Ishizawa, Hidetomo Kitamura

Bioorg Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AG-041R, a novel indoline-2-one derivative, stimulates chondrogenesis in a bipotent chondroprogenitor cell line CL-1.
Hidetomo Kitamura, Makoto Okazaki

Osteoarthritis Cartilage· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a bipotent cell line CL-1 which differentiates into chondrocytes and adipocytes from adult mouse.
Hidetomo Kitamura

Osteoarthritis Cartilage· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in dogs with chronic renal failure.
Fumiaki Takahashi, Tatsuya Furuichi, Keigo Yorozu, Setsu Kawata, Hidetomo Kitamura

Nephrol Dial Transplant· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammalian twisted gastrulation is essential for skeleto-lymphogenesis.
Tetsuya Nosaka, Sumiyo Morita, Hidetomo Kitamura, Hideaki Nakajima, Fumi Shibata, Toshio Kitamura

Mol Cell Biol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Effects of intravenous and oral OCT on secondary hyperparathyroidism in dogs with chronic renal failure].
Fumiaki Takahashi, Keigo Yorozu, Yuki Kawata, Hidetomo Kitamura, Nobuyuki Chiba

Clin Calcium· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis